These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 4942320

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Malignancies in recipients of organ transplants.
    Penn I.
    Johns Hopkins Med J Suppl; 1974; 3():211-21. PubMed ID: 4608179
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Significance of immunosuppression for the origin and growth of malignant tumors].
    Reis HE.
    Dtsch Med Wochenschr; 1971 Jan 22; 96(4):170-4. PubMed ID: 4992740
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Bases of immunosuppression and immunostimulation including their side effects in immunopathological diseases].
    Deicher H.
    Verh Dtsch Ges Inn Med; 1971 Jan 22; 83():773-82. PubMed ID: 612054
    [No Abstract] [Full Text] [Related]

  • 7. [Why does a tumor grow?].
    Dosne Pasqualini C, Laguens RP, Colmerauer ME, Segal A.
    Medicina (B Aires); 1974 Jan 22; 34(6):659-64. PubMed ID: 4617837
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Immunosuppression and malignant neoplasms.
    Simmons RL, Najarian JS.
    N Engl J Med; 1970 Oct 22; 283(17):934-5. PubMed ID: 4917728
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Incidence of cancer after immunosuppressive treatment for heart transplantation.
    Ippoliti G, Rinaldi M, Pellegrini C, Viganò M.
    Crit Rev Oncol Hematol; 2005 Oct 22; 56(1):101-13. PubMed ID: 15979322
    [Abstract] [Full Text] [Related]

  • 12. Immunosuppression and malignant neoplasms.
    Starzl TE, Penn I, Halgrimson CG.
    N Engl J Med; 1970 Oct 22; 283(17):934. PubMed ID: 4917727
    [No Abstract] [Full Text] [Related]

  • 13. Malignant disease in immunodeficient states in man.
    Penn I.
    Recent Results Cancer Res; 1975 Oct 22; (52):96-106. PubMed ID: 796918
    [No Abstract] [Full Text] [Related]

  • 14. [Study of new immunodepressants among antineoplastic agents].
    Drake RB, Grigalinovich GA, Kalnberz VK, Lidak MIu.
    Vestn Akad Med Nauk SSSR; 1971 Oct 22; 26(1):31-3. PubMed ID: 4928209
    [No Abstract] [Full Text] [Related]

  • 15. Immunosuppression by antilymphocyte serum and its effect on tumors indduced by 3-methylcholanthrene in mice.
    Wagner JL, Haughton G.
    J Natl Cancer Inst; 1971 Jan 22; 46(1):1-10. PubMed ID: 5546191
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The use of tumor growth kinetics in planning "curative" chemotherapy of advanced solid tumors.
    Schabel FM.
    Cancer Res; 1969 Dec 22; 29(12):2384-9. PubMed ID: 5369685
    [No Abstract] [Full Text] [Related]

  • 19. [Malignant tumors under immunosuppression, new problem in transplant recipients].
    Enderlin F, Guisan Y.
    Schweiz Rundsch Med Prax; 1973 Aug 21; 62(34):1031-5. PubMed ID: 4582307
    [No Abstract] [Full Text] [Related]

  • 20. Immunosuppression and neoplasia.
    Balner H.
    Rev Eur Etud Clin Biol; 1970 Aug 21; 15(6):599-604. PubMed ID: 4919177
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.